文献速递腹部技术与安全CT

四级肿瘤医院急诊科CT口服对比剂使用效用:诊断意义、周转时间及急诊医师开单评估

Utility of CT oral contrast administration in the emergency department of a quaternary oncology hospital: diagnostic implications, turnaround times, and assessment of ED physician ordering.
PubMed 文献 · Abdom Radiol (NY) · 2017-01-01

该回顾性研究纳入267例急诊肿瘤患者腹部CT,比较口服对比剂与未用口服对比剂在诊断信心与诊断能力上的差异,并计算从开单到检查开始的周转时间。结果显示两组在诊断信心与诊断能力改善方面无显著差异,但口服对比剂组周转时间显著延长(平均141分钟 vs 109.2分钟,平均差31.8分钟,P<0.0001)。作者认为在急诊肿瘤患者中,针对性而非默认使用口服对比剂显示出可接受的诊断能力。

要点

  • 急诊肿瘤患者腹部CT使用口服对比剂未显著改善诊断信心或诊断能力。
  • 口服对比剂组从开单到CT开始的平均周转时间较未用组延长31.8分钟(P<0.0001)。
  • 作者认为针对性使用口服对比剂在急诊肿瘤患者中诊断能力可接受。

核心结论

  • 基于本研究及既往研究,针对性而非默认使用口服对比剂在急诊肿瘤患者中显示出可接受的诊断能力;在疑似瘘/肠漏/脓肿、低密度腹膜病变、既往肠道手术如胃旁路术及未使用静脉对比剂等场景中,口服对比剂使用可能获益。

研究设计与样本

  • 回顾性研究,纳入一个月内急诊就诊的肿瘤患者腹部CT检查共267例(男127例,女140例,平均年龄56岁,平均体重指数27.8 kg/m2),其中160例未用口服对比剂、107例使用口服对比剂;由两名共识阅片者评估诊断信心与诊断能力。

诊断标准与关键数值

  • 口服对比剂组与未用组相比,评为「诊断信心改善」的比值比OR 0.54(95%CI 0.23-1.31,P=0.17),无显著差异。
  • 口服对比剂组与未用组相比,评为「诊断能力改善」的比值比OR 0.58(95%CI 0.20-1.64,P=0.3),无显著差异。
  • 口服对比剂组与未用组相比,评为「诊断信心受损」的比值比OR 3.92(95%CI 0.46-33.06,P=0.21),无显著差异。
  • 口服对比剂组与未用组相比,评为「诊断能力受损」的比值比OR 2.63(95%CI 0.29-23.89,P=0.39),无显著差异。
  • 口服对比剂组从开单到CT开始的平均周转时间为141分钟(标准差49.8分钟),未用组为109.2分钟(标准差64.8分钟),平均差31.8分钟(P<0.0001)。

临床应用与阅片要点

  • 作者认为在急诊肿瘤患者中可针对性而非默认使用口服对比剂,疑似瘘/肠漏/脓肿、低密度腹膜病变、既往肠道手术如胃旁路术及未使用静脉对比剂等场景可能获益;口服对比剂会延长从开单到检查开始的周转时间。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare studies with and without oral contrast on performance of multidetector computed tomography (CT) and the order to CT examination turnaround time in cancer patients presenting to the emergency department (ED). To the best of our knowledge, oral contrast utility has not previously been specifically assessed in cancer patients presenting to the emergency department.

MATERIALS &amp; METHODS: Retrospective review of CT abdomen examinations performed in oncology patients presenting to the emergency department during one month. CT examinations performed with and without oral contrast were rated by two consensus readers for degree of confidence and diagnostic ability. Correlations were assessed for primary cancer type, age, sex, chief complaint/examination indication, body mass index, intravenous contrast status, repeat CT examination within 4 weeks, and disposition. Turnaround times from order to the start of the CT examination were calculated.

RESULTS: The studied group consisted of 267 patients (127 men and 140 women) with a mean age of 56 years and a mean body mass index of 27.8 kg/m2. One hundred sixty CT examinations were performed without oral contrast, and 107 CT examinations were performed with oral contrast. There was no significant difference between cases with oral contrast and cases without oral contrast in the number of cases rated as "improved confidence" (odds ratio [OR] 0.54, 95% confidence interval [CI] 0.23-1.31, P = 0.17), "improved diagnosis" (OR 0.58, 95% CI 0.20-1.64, P = 0.3), "impaired confidence" (OR 3.92, 95% CI 0.46-33.06, P = 0.21), or "impaired diagnosis" (OR 2.63, 95% CI 0.29-23.89, P = 0.39). The turnaround time in the group receiving oral contrast (mean, 141 min; standard deviation, 49.8 min) was significantly longer than that in the group not receiving oral contrast (mean, 109.2 min; standard deviation, 64.8 min) with a mean difference of 31.8 min (P < 0.0001).

CONCLUSION: On the basis of our findings and prior studies, targeted rather than default use of oral contrast shows acceptable diagnostic ability in the emergency setting for oncology patients. Benefit from oral contrast use is suggested in scenarios such as suspected fistula/bowel leak/abscess, hypoattenuating peritoneal disease, prior bowel surgery such as gastric bypass, and the absence of intravenous contrast administration. Improvement through the use of targeted oral contrast administration also supports the emergency department need for prompt diagnosis and disposition.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Jensen CT, Blair KJ, Le O, et al. Utility of CT oral contrast administration in the emergency department of a quaternary oncology hospital: diagnostic implications, turnaround times, and assessment of ED physician ordering. Abdom Radiol (NY). 2017. PMID: 28523416. doi:10.1007/s00261-017-1175-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。